Charles Schwab Investment Management Inc Charles River Laboratories International, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 552,975 shares of CRL stock, worth $85.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
552,975
Previous 515,222
7.33%
Holding current value
$85.7 Million
Previous $101 Million
0.58%
% of portfolio
0.02%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
51.4MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.16MShares$954 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$788 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$631 Million0.14% of portfolio
-
State Street Corp Boston, MA2.13MShares$330 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$300 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.88B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...